Acamprosate Completed Phase 4 Trials for Alcohol Dependence / Generalized Anxiety Disorder (GAD) / Major Depressive Disorder (MDD) / Social Anxiety Disorder (SAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00159107Integrative Therapy in Alcoholism
NCT00855699Alcohol Detoxification in Primary Care Treatment (ADEPT)
NCT00435435Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
NCT00381043Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic
NCT00330174Acamprosate in Alcoholics With Comorbid Anxiety or Depression